Skip to main content
Top
Published in: Acta Diabetologica 3/2018

01-03-2018 | Original Article

Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?

Authors: Véronique Gingras, Katherine Desjardins, Mohamed Raef Smaoui, Valérie Savard, Virginie Messier, Ahmad Haidar, Laurent Legault, Rémi Rabasa-Lhoret

Published in: Acta Diabetologica | Issue 3/2018

Login to get access

Abstract

Aims

Mild-to-moderate hypoglycemia (blood glucose < 4.0 mmol/L) is recommended to be treated with 15 g of carbohydrates and to repeat the treatment if hypoglycemia persists after 15 min. This recommendation was established before intensive insulin therapy and based on studies using insulin with different pharmacokinetic profiles from actual insulin analogs showing that 15 g of glucose increases blood glucose by ~ 1.5 mmol/L in 15 min. We aimed to explore the effect of current recommended treatment of mild-to-moderate hypoglycemia in type 1 diabetes (T1D) participants and factors associated with treatment effectiveness.

Methods

This is a secondary analysis from three observational inpatient studies with a standardized and supervised treatment (16 g carbohydrates) of hypoglycemia (< 3.3 mmol/L with symptoms or < 3.0 mmol/L without symptom) in participants (47 adults–10 adolescents) with T1D using continuous subcutaneous insulin infusion (“insulin pumps”; CSII)).

Results

Twenty-seven participants presented a total of 48 hypoglycemia episodes treated by a single intake of 16 g of carbohydrates. Time required for normoglycemia recovery was 19.5 ± 12.0 min. The rise in plasma glucose following treatment was 0.85 ± 0.66 mmol/L in 15 min. Eighteen episodes (38%) were resolved (> 4.0 mmol/L) 15-min post-treatment. Glycemia at the time of treatment (< 3.2 mmol/L; p < 0.001) and a higher proportion of total daily insulin from basal doses (p = 0.03) were associated with a slower post-treatment plasma glucose rise.

Conclusions

These results raise the possibility that sixteen grams of carbohydrates could be insufficient to treat a large proportion of hypoglycemia episodes in T1D patients treated with CSII. Factors affecting treatment effectiveness need to be investigated.
Appendix
Available only for authorised users
Literature
1.
go back to reference The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–986CrossRef
2.
go back to reference Clayton D, Woo V, Yale JF, Canadian Diabetes Association Clinical Practice Guidelines Expert C (2013) Hypoglycemia. Can J Diabetes 37(Suppl 1):S69–S71CrossRefPubMed Clayton D, Woo V, Yale JF, Canadian Diabetes Association Clinical Practice Guidelines Expert C (2013) Hypoglycemia. Can J Diabetes 37(Suppl 1):S69–S71CrossRefPubMed
3.
go back to reference Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H (2008) Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31(11):2108–2109CrossRefPubMedPubMedCentral Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H (2008) Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31(11):2108–2109CrossRefPubMedPubMedCentral
4.
go back to reference American Diabetes Association (2016) Standards of medical care in diabetes. Diabetes Care 39(Suppl. 1):S72–S80 American Diabetes Association (2016) Standards of medical care in diabetes. Diabetes Care 39(Suppl. 1):S72–S80
5.
go back to reference Banck-Petersen P, Larsen T, Pedersen-Bjergaard U, Due-Andersen R, Høi-Hansen T, Thorsteinsson B (2007) Adherence to guidelines for self-treatment of mild hypoglycaemia in type 1 diabetes. Eur Diabetes Nurs 4(1):18–22CrossRef Banck-Petersen P, Larsen T, Pedersen-Bjergaard U, Due-Andersen R, Høi-Hansen T, Thorsteinsson B (2007) Adherence to guidelines for self-treatment of mild hypoglycaemia in type 1 diabetes. Eur Diabetes Nurs 4(1):18–22CrossRef
6.
go back to reference Sally A, Vindedziz BM, Sherriff JL, Dhaliwal SS, Stanton KG (2012) Food selection for treatment of hypoglycaemia in insulin-treated diabetes: what happens in real life? Pract Diabetes 29(7):271–274CrossRef Sally A, Vindedziz BM, Sherriff JL, Dhaliwal SS, Stanton KG (2012) Food selection for treatment of hypoglycaemia in insulin-treated diabetes: what happens in real life? Pract Diabetes 29(7):271–274CrossRef
7.
go back to reference Savard V, Gingras V, Leroux C, Bertrand A, Desjardins K, Mircescu H, Rabasa-Lhoret R (2016) Treatment of hypoglycemia in adult patients with type 1 diabetes: an observational study. Can J Diabetes 40(4):318–323CrossRefPubMed Savard V, Gingras V, Leroux C, Bertrand A, Desjardins K, Mircescu H, Rabasa-Lhoret R (2016) Treatment of hypoglycemia in adult patients with type 1 diabetes: an observational study. Can J Diabetes 40(4):318–323CrossRefPubMed
8.
go back to reference Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R (2015) Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 3(1):17–26CrossRefPubMed Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R (2015) Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 3(1):17–26CrossRefPubMed
9.
go back to reference Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R (2013) Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 185(4):297–305CrossRefPubMedPubMedCentral Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R (2013) Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 185(4):297–305CrossRefPubMedPubMedCentral
10.
go back to reference Gingras V, Rabasa-Lhoret R, Messier V, Ladouceur M, Legault L, Haidar A (2016) Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: a randomized crossover trial. Diabetes Metab 42(1):47–54CrossRefPubMed Gingras V, Rabasa-Lhoret R, Messier V, Ladouceur M, Legault L, Haidar A (2016) Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: a randomized crossover trial. Diabetes Metab 42(1):47–54CrossRefPubMed
11.
go back to reference Slama G, Traynard PY, Desplanque N, Pudar H, Dhunputh I, Letanoux M, Bornet FR, Tchobroutsky G (1990) The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solution, or gel for the correction of insulin reactions. Arch Intern Med 150(3):589–593CrossRefPubMed Slama G, Traynard PY, Desplanque N, Pudar H, Dhunputh I, Letanoux M, Bornet FR, Tchobroutsky G (1990) The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solution, or gel for the correction of insulin reactions. Arch Intern Med 150(3):589–593CrossRefPubMed
12.
go back to reference Brodows RG, Williams C, Amatruda JM (1984) Treatment of insulin reactions in diabetics. JAMA 252(24):3378–3381CrossRefPubMed Brodows RG, Williams C, Amatruda JM (1984) Treatment of insulin reactions in diabetics. JAMA 252(24):3378–3381CrossRefPubMed
13.
go back to reference The Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47(6):1703–1720 The Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47(6):1703–1720
14.
go back to reference Diabetes Control and Complications Trial Research Group (2001) Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 24(10):1711–1721CrossRef Diabetes Control and Complications Trial Research Group (2001) Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 24(10):1711–1721CrossRef
15.
go back to reference Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB et al (2014) Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 37(10):2702–2709CrossRefPubMedPubMedCentral Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB et al (2014) Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 37(10):2702–2709CrossRefPubMedPubMedCentral
16.
go back to reference Benkhadra K, Alahdab F, Tamhane S, Wang Z, Prokop LJ, Hirsch IB, Raccah D, Riveline JP, Kordonouri O, Murad MH (2017) Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis. Clin Endocrinol (Oxf) 86(3):354–360CrossRef Benkhadra K, Alahdab F, Tamhane S, Wang Z, Prokop LJ, Hirsch IB, Raccah D, Riveline JP, Kordonouri O, Murad MH (2017) Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis. Clin Endocrinol (Oxf) 86(3):354–360CrossRef
17.
go back to reference King AB, Kuroda A, Matsuhisa M, Hobbs T (2016) A review of insulin-dosing formulas for continuous subcutaneous insulin infusion (CSII) for adults with type 1 diabetes. Curr Diab Rep 16(9):83CrossRefPubMedPubMedCentral King AB, Kuroda A, Matsuhisa M, Hobbs T (2016) A review of insulin-dosing formulas for continuous subcutaneous insulin infusion (CSII) for adults with type 1 diabetes. Curr Diab Rep 16(9):83CrossRefPubMedPubMedCentral
18.
go back to reference McTavish L, Krebs JD, Weatherall M, Wiltshire E (2015) Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: a randomized crossover clinical trial. Diabet Med 32(9):1143–1148CrossRefPubMed McTavish L, Krebs JD, Weatherall M, Wiltshire E (2015) Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: a randomized crossover clinical trial. Diabet Med 32(9):1143–1148CrossRefPubMed
19.
go back to reference Vindedzis S, Marsh B, Sherriff J, Dhaliwal S, Stanton K (2012) Dietary treatment of hypoglycaemia: should the Australian recommendation be increased? Intern Med J 42(7):830–833CrossRefPubMed Vindedzis S, Marsh B, Sherriff J, Dhaliwal S, Stanton K (2012) Dietary treatment of hypoglycaemia: should the Australian recommendation be increased? Intern Med J 42(7):830–833CrossRefPubMed
20.
Metadata
Title
Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?
Authors
Véronique Gingras
Katherine Desjardins
Mohamed Raef Smaoui
Valérie Savard
Virginie Messier
Ahmad Haidar
Laurent Legault
Rémi Rabasa-Lhoret
Publication date
01-03-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1085-8

Other articles of this Issue 3/2018

Acta Diabetologica 3/2018 Go to the issue